Key points are not available for this paper at this time.
Stakeholders should recognize HBPC as an intervention that decreases patient care costs at end of life and therefore health care providers should assess the preferences of patients nearing the end-of-life to identify those who will benefit most from HBPC.
González-Jaramillo et al. (Wed,) studied this question.